Literature DB >> 3949233

Relapse of acute B viral hepatitis--role of delta agent.

S Govindarajan, B Valinluck, L Peters.   

Abstract

Serologic markers for delta agent were evaluated in 39 patients with acute hepatitis B and clinical relapse within 30 days from the initial episode. Eighteen of the 39 patients (46%) had evidence of acute delta infection. Delta antigenaemia preceded the appearance of antibodies in seven of these 18 patients; delta antigenaemia occurred during the initial episode of illness and the appearance of the antibody coincided with the relapse. Eight of these patients developed severe relapse with fulminant course which resulted in two deaths. This study reveals that delta infection is one of the important causes of severe relapse in cases of acute B viral hepatitis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3949233      PMCID: PMC1433161          DOI: 10.1136/gut.27.1.19

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  14 in total

1.  Multiple attacks of hepatitis in drug addicts: biochemical, immunochemical, and morphologic characteristics.

Authors:  S Iwarson; P Lundin; J Holmgren; S Hermodsson
Journal:  J Infect Dis       Date:  1973-05       Impact factor: 5.226

2.  Infection with the delta agent in chronic HBsAg carriers.

Authors:  A Smedile; P Dentico; A Zanetti; E Sagnelli; E Nordenfelt; G C Actis; M Rizzetto
Journal:  Gastroenterology       Date:  1981-12       Impact factor: 22.682

3.  The natural history of liver disease in former drug users.

Authors:  C E Cherubin; R A Schaefer; W S Rosenthal; T McGinn; F Forte; R Purcell; P Walmsley
Journal:  Am J Med Sci       Date:  1976 Nov-Dec       Impact factor: 2.378

4.  Multicentre study of prevalence of HBV-associated delta infection and liver disease in drug-addicts.

Authors:  G Raimondo; A Smedile; L Gallo; A Balbo; A Ponzetto; M Rizzetto
Journal:  Lancet       Date:  1982-01-30       Impact factor: 79.321

5.  Prevalence of delta-antibody among chronic hepatitis B virus infected patients in the Los Angeles area: its correlation with liver biopsy diagnosis.

Authors:  S Govindarajan; G C Kanel; R L Peters
Journal:  Gastroenterology       Date:  1983-07       Impact factor: 22.682

6.  The delta agent: HBsAg particles with delta antigen and RNA in the serum of an HBV carrier.

Authors:  F Bonino; B Hoyer; E Ford; J W Shih; R H Purcell; J L Gerin
Journal:  Hepatology       Date:  1981 Mar-Apr       Impact factor: 17.425

7.  Delta agent infection in Melbourne.

Authors:  J F Hoy; B G Hansson; M Dimitrakakis; I Gust; C R Lucas
Journal:  J Med Virol       Date:  1984       Impact factor: 2.327

8.  IgM antibody to hepatitis B core antigen as a diagnostic parameter of acute infection with hepatitis B virus.

Authors:  S M Lemon; N L Gates; T E Simms; W H Bancroft
Journal:  J Infect Dis       Date:  1981-06       Impact factor: 5.226

9.  Chronic hepatitis in carriers of hepatitis B surface antigen, with intrahepatic expression of the delta antigen. An active and progressive disease unresponsive to immunosuppressive treatment.

Authors:  M Rizzetto; G Verme; S Recchia; F Bonino; P Farci; S Aricò; R Calzia; A Picciotto; M Colombo; H Popper
Journal:  Ann Intern Med       Date:  1983-04       Impact factor: 25.391

10.  Clinical aspects of delta infection.

Authors:  T Moestrup; B G Hansson; A Widell; E Nordenfelt
Journal:  Br Med J (Clin Res Ed)       Date:  1983-01-08
View more
  8 in total

1.  Acute hepatitis B and hepatitis D co-infection in the Stockholm region in the 1970s and 1980s--a comparison.

Authors:  G Lindh; L Mattsson; M von Sydow; O Weiland
Journal:  Infection       Date:  1990 Nov-Dec       Impact factor: 3.553

Review 2.  Medical complications of intravenous drug use.

Authors:  M D Stein
Journal:  J Gen Intern Med       Date:  1990 May-Jun       Impact factor: 5.128

3.  Biphasic hepatitis in HBV/HDV coinfected parenteral drug abusers.

Authors:  F Caredda; S Antinori; T Re; C Pastecchia; M Moroni
Journal:  Gut       Date:  1986-06       Impact factor: 23.059

4.  Hepatitis D virus infection, replication and cross-talk with the hepatitis B virus.

Authors:  Chi-Ruei Huang; Szecheng John Lo
Journal:  World J Gastroenterol       Date:  2014-10-28       Impact factor: 5.742

5.  Hepatitis delta virus RNA in serum of patients with chronic delta hepatitis.

Authors:  L H Simpson; M Battegay; J H Hoofnagle; J G Waggoner; A M Di Bisceglie
Journal:  Dig Dis Sci       Date:  1994-12       Impact factor: 3.199

6.  Correlation of hepatitis B virus, hepatitis D virus and human immunodeficiency virus type I infection markers in hepatitis B surface antigen positive haemophiliacs and patients without haemophilia with clinical and histopathological outcome of hepatitis.

Authors:  N Wagner; H W Rotthauwe; M Becker; H P Dienes; T Mertens; H J Födisch; H H Brackmann
Journal:  Eur J Pediatr       Date:  1992-02       Impact factor: 3.183

Review 7.  Delta and non-A, non-B hepatitis viruses.

Authors:  F Bonino; M Baldi; A Demartini
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-06       Impact factor: 3.267

8.  Clinical features of hepatitis delta virus infection in a northern Italian area.

Authors:  G Pasetti; C Calzetti; A Degli Antoni; C Ferrari; A Penna; F Fiaccadori
Journal:  Infection       Date:  1988       Impact factor: 3.553

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.